Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gynecologic Oncology

Breast Cancer

Multiple Myeloma

Lung Cancer

Immuno-Oncology News

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Gynecologic Oncology

NICE Approves Maintenance Rucaparib for Relapsed Ovarian Cancer

The UK’s National Institute for Health and Care Excellence has approved rucaparib for the maintenance treatment of patients with relapsed ovarian, fallopian tube, or peritoneal cancer that has responded to platinum-based chemotherapy.
Read More >>

Olaparib/Durvalumab Combo Shows Promising Long-Term Activity in Germline BRCA+ Breast, Ovarian Cancer

PARP Inhibitors Continue to Flourish in Advanced Ovarian Cancer

Trametinib Emerges as New Standard Option for Recurrent, Low-Grade Ovarian Cancer

ESMO 2019: Nivolumab/Ipilimumab Combo Delivers Durable Clinical Activity in Cervical Cancer

ESMO 2019: Frontline Olaparib/Bevacizumab Maintenance Combo Extends PFS in Ovarian Cancer

View More Stories >>

View Conference Coverage

2019 Hairy Cell Leukemia Foundation Annual Conference

2019 Lynn Sage Breast Cancer Symposium

2019 ESMO Congress

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

Dr. Gonzalez-Martin on Rationale for Phase III PRIMA Trial in Advanced Ovarian Cancer

Dr. Hong on Moving Tisotumab Vedotin to Frontline Therapy for Cervical Cancer

Dr. Backes on Rationale for Lenvatinib and Weekly Paclitaxel in Endometrial Cancer

Dr. Coleman on Rationale for Using Veliparib and Chemotherapy in Ovarian Cancer

Dr. Coleman on the Use of Immunotherapy in Cervical Cancer

Dr. Ledermann on Rationale for ARIEL3 Trial in Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Future of Managing Gynecologic Cancer

Standard Frontline Therapy for Endometrial Cancer

Updates in Testing Endometrial Cancer Biomarkers

Frontline Therapies for Metastatic Cervical Cancer

Cervical Cancer: Staging and Minimally Invasive Surgery

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in Advanced Ovarian Cancer Management

Genetic Counseling for Patients With Ovarian Cancer

Sequencing Antiangiogenic Agents in Advanced Ovarian Cancer

Sequencing PARP Inhibitors in Advanced Ovarian Cancer

Prepping Patients With Advanced OC for PARP Inhibition

Management of PARP Inhibitor AEs in Ovarian Cancer

Impact of SOLO-1 on Advanced Ovarian Cancer Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

This discussion, led by James Tate Thigpen, MD, features the most recent information pertaining to treatment of gynecologic malignancies. The expert panel, Robert L. Coleman, MD, FACOG, FACS; Thomas Herzog, MD; Bradley J. Monk, MD, FACOG, FACS; and Angeles Alvarez Secord, MD, review the research and how to apply it in practice.View Now

Challenges for the Future of Gynecologic Cancers

Panelists provide their perspectives on the key challenges facing the future of ovarian and cervical cancer treatment.View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval in Myeloma, Label Update in HER2+ Breast Cancer, Breakthrough Status in Prostate Cancer, and More